ALB and hepatocellular carcinoma: Pons et al.reported that albumin level at baseline and regression of LSM after SVR during follow-up were independently associated with the risk of HCC in 572 patients with LSM ≥ 10 kPa before treatment during a median follow-up of 2.9 years18.